{"entity":{"type":"insider","cik":"0001948238","url":"/insider/0001948238","json_url":"/insider/0001948238.json","name":"Pizzuti Dana","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":17,"first":"2023-04-05","last":"2025-12-03","span_basis":"filed_date"},"name_variants":[{"name":"Pizzuti Dana","source":"filing","n_filings":17,"first_seen":"2023-04-05","last_seen":"2025-12-03"}],"transactions":[{"id":4840370,"accession":"0001628280-25-055054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-25-055054","line_url":"/filing/0001628280-25-055054#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001948238","owner_name":"Pizzuti Dana","owner_url":"/insider/0001948238","role":"Officer (Chief Med and Dev Officer)","officer_title":"Chief Med and Dev Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":45.02,"price_display":"45.02","price_state":"stated","total_value":225100.0,"total_display":"225,100.00","shares_owned_after":66837.0,"shares_owned_after_display":"66,837","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-01","filed_date":"2025-12-03","scope":"insider"},{"id":4148921,"accession":"0001628280-25-049671","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-25-049671","line_url":"/filing/0001628280-25-049671#line-3","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001948238","owner_name":"Pizzuti Dana","owner_url":"/insider/0001948238","role":"Officer (Chief Med and Dev Officer)","officer_title":"Chief Med and Dev Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4900.0,"shares_display":"4,900","price_per_share":42.65,"price_display":"42.65","price_state":"stated","total_value":208985.0,"total_display":"208,985.00","shares_owned_after":66370.0,"shares_owned_after_display":"66,370","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-03","filed_date":"2025-11-05","scope":"insider"},{"id":4148918,"accession":"0001628280-25-049671","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-25-049671","line_url":"/filing/0001628280-25-049671#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001948238","owner_name":"Pizzuti Dana","owner_url":"/insider/0001948238","role":"Officer (Chief Med and Dev Officer)","officer_title":"Chief Med and Dev Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":43.27,"price_display":"43.27","price_state":"stated","total_value":4327.0,"total_display":"4,327.00","shares_owned_after":66270.0,"shares_owned_after_display":"66,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-03","filed_date":"2025-11-05","scope":"insider"},{"id":4678099,"accession":"0001658247-25-000013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001658247-25-000013","line_url":"/filing/0001658247-25-000013#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001948238","owner_name":"Pizzuti Dana","owner_url":"/insider/0001948238","role":"Officer (Chief Med and Dev Officer)","officer_title":"Chief Med and Dev Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":41.81,"price_display":"41.81","price_state":"stated","total_value":209050.0,"total_display":"209,050.00","shares_owned_after":66270.0,"shares_owned_after_display":"66,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-01","filed_date":"2025-10-03","scope":"insider"},{"id":4215659,"accession":"0001948238-25-000009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001948238-25-000009","line_url":"/filing/0001948238-25-000009#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001948238","owner_name":"Pizzuti Dana","owner_url":"/insider/0001948238","role":"Officer (Chief Med and Dev Officer)","officer_title":"Chief Med and Dev Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":32.1,"price_display":"32.10","price_state":"stated","total_value":160500.0,"total_display":"160,500.00","shares_owned_after":96270.0,"shares_owned_after_display":"96,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-02","filed_date":"2025-09-04","scope":"insider"},{"id":4645430,"accession":"0001948238-25-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001948238-25-000007","line_url":"/filing/0001948238-25-000007#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001948238","owner_name":"Pizzuti Dana","owner_url":"/insider/0001948238","role":"Officer (Chief Med and Dev Officer)","officer_title":"Chief Med and Dev Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":30.43,"price_display":"30.43","price_state":"stated","total_value":912900.0,"total_display":"912,900.00","shares_owned_after":66270.0,"shares_owned_after_display":"66,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-22","filed_date":"2025-08-26","scope":"insider"},{"id":4078167,"accession":"0001948238-25-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001948238-25-000005","line_url":"/filing/0001948238-25-000005#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001948238","owner_name":"Pizzuti Dana","owner_url":"/insider/0001948238","role":"Officer (Chief Med and Dev Officer)","officer_title":"Chief Med and Dev Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6492.0,"shares_display":"6,492","price_per_share":29.18,"price_display":"29.18","price_state":"stated","total_value":189436.56,"total_display":"189,436.56","shares_owned_after":66270.0,"shares_owned_after_display":"66,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-20","filed_date":"2025-08-21","scope":"insider"},{"id":5117578,"accession":"0000950170-25-043407","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-043407","line_url":"/filing/0000950170-25-043407#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001948238","owner_name":"Pizzuti Dana","owner_url":"/insider/0001948238","role":"Officer (Chief Med and Dev Officer)","officer_title":"Chief Med and Dev Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2388.0,"shares_display":"2,388","price_per_share":34.17,"price_display":"34.17","price_state":"stated","total_value":81597.96,"total_display":"81,597.96","shares_owned_after":72360.0,"shares_owned_after_display":"72,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-19","filed_date":"2025-03-21","scope":"insider"},{"id":5117576,"accession":"0000950170-25-043407","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-043407","line_url":"/filing/0000950170-25-043407#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001948238","owner_name":"Pizzuti Dana","owner_url":"/insider/0001948238","role":"Officer (Chief Med and Dev Officer)","officer_title":"Chief Med and Dev Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":127.0,"shares_display":"127","price_per_share":34.83,"price_display":"34.83","price_state":"stated","total_value":4423.41,"total_display":"4,423.41","shares_owned_after":72233.0,"shares_owned_after_display":"72,233","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-19","filed_date":"2025-03-21","scope":"insider"},{"id":5030349,"accession":"0000950170-25-014557","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-014557","line_url":"/filing/0000950170-25-014557#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001948238","owner_name":"Pizzuti Dana","owner_url":"/insider/0001948238","role":"Officer (Chief Med and Dev Officer)","officer_title":"Chief Med and Dev Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":39.07,"price_display":"39.07","price_state":"stated","total_value":195350.0,"total_display":"195,350.00","shares_owned_after":31748.0,"shares_owned_after_display":"31,748","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-05","scope":"insider"},{"id":4375494,"accession":"0000950170-25-002869","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-002869","line_url":"/filing/0000950170-25-002869#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001948238","owner_name":"Pizzuti Dana","owner_url":"/insider/0001948238","role":"Officer (Chief Med and Dev Officer)","officer_title":"Chief Med and Dev Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":52.09,"price_display":"52.09","price_state":"stated","total_value":781350.0,"total_display":"781,350.00","shares_owned_after":29248.0,"shares_owned_after_display":"29,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-03","filed_date":"2025-01-07","scope":"insider"},{"id":2039697,"accession":"0000950170-24-113082","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-113082","line_url":"/filing/0000950170-24-113082#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001948238","owner_name":"Pizzuti Dana","owner_url":"/insider/0001948238","role":"Officer (Chief Med and Dev Officer)","officer_title":"Chief Med and Dev Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14375.0,"shares_display":"14,375","price_per_share":54.63,"price_display":"54.63","price_state":"stated","total_value":785306.25,"total_display":"785,306.25","shares_owned_after":28507.0,"shares_owned_after_display":"28,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-03","filed_date":"2024-10-07","scope":"insider"},{"id":2082395,"accession":"0000950170-24-081878","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-081878","line_url":"/filing/0000950170-24-081878#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001948238","owner_name":"Pizzuti Dana","owner_url":"/insider/0001948238","role":"Officer (Chief Med and Dev Officer)","officer_title":"Chief Med and Dev Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14375.0,"shares_display":"14,375","price_per_share":44.87,"price_display":"44.87","price_state":"stated","total_value":645006.25,"total_display":"645,006.25","shares_owned_after":28507.0,"shares_owned_after_display":"28,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-03","filed_date":"2024-07-05","scope":"insider"},{"id":2205684,"accession":"0000950170-24-077402","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-077402","line_url":"/filing/0000950170-24-077402#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001948238","owner_name":"Pizzuti Dana","owner_url":"/insider/0001948238","role":"Officer (Chief Med and Dev Officer)","officer_title":"Chief Med and Dev Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9500.0,"shares_display":"9,500","price_per_share":45.73,"price_display":"45.73","price_state":"stated","total_value":434435.0,"total_display":"434,435.00","shares_owned_after":27786.0,"shares_owned_after_display":"27,786","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-24","filed_date":"2024-06-25","scope":"insider"},{"id":3254133,"accession":"0000950170-24-045142","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-045142","line_url":"/filing/0000950170-24-045142#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001948238","owner_name":"Pizzuti Dana","owner_url":"/insider/0001948238","role":"Officer (Chief Med and Dev Officer)","officer_title":"Chief Med and Dev Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14375.0,"shares_display":"14,375","price_per_share":44.47,"price_display":"44.47","price_state":"stated","total_value":639256.25,"total_display":"639,256.25","shares_owned_after":27786.0,"shares_owned_after_display":"27,786","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-15","filed_date":"2024-04-17","scope":"insider"},{"id":2213853,"accession":"0001209191-24-005061","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-24-005061","line_url":"/filing/0001209191-24-005061#line-5","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001948238","owner_name":"Pizzuti Dana","owner_url":"/insider/0001948238","role":"Officer (Chief Med and Dev Officer)","officer_title":"Chief Med and Dev Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":43.28,"price_display":"43.28","price_state":"stated","total_value":432800.0,"total_display":"432,800.00","shares_owned_after":28500.0,"shares_owned_after_display":"28,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-20","filed_date":"2024-03-22","scope":"insider"},{"id":2213850,"accession":"0001209191-24-005061","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-24-005061","line_url":"/filing/0001209191-24-005061#line-4","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001948238","owner_name":"Pizzuti Dana","owner_url":"/insider/0001948238","role":"Officer (Chief Med and Dev Officer)","officer_title":"Chief Med and Dev Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4375.0,"shares_display":"4,375","price_per_share":45.89,"price_display":"45.89","price_state":"stated","total_value":200768.75,"total_display":"200,768.75","shares_owned_after":28500.0,"shares_owned_after_display":"28,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-20","filed_date":"2024-03-22","scope":"insider"},{"id":2213847,"accession":"0001209191-24-005061","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-24-005061","line_url":"/filing/0001209191-24-005061#line-3","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001948238","owner_name":"Pizzuti Dana","owner_url":"/insider/0001948238","role":"Officer (Chief Med and Dev Officer)","officer_title":"Chief Med and Dev Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":714.0,"shares_display":"714","price_per_share":43.69,"price_display":"43.69","price_state":"stated","total_value":31194.66,"total_display":"31,194.66","shares_owned_after":27786.0,"shares_owned_after_display":"27,786","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-20","filed_date":"2024-03-22","scope":"insider"},{"id":2697782,"accession":"0001209191-24-000816","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-000816","line_url":"/filing/0001209191-24-000816#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001948238","owner_name":"Pizzuti Dana","owner_url":"/insider/0001948238","role":"Officer (Chief Med and Dev Officer)","officer_title":"Chief Med and Dev Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14375.0,"shares_display":"14,375","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":503125.0,"total_display":"503,125.00","shares_owned_after":5911.0,"shares_owned_after_display":"5,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-04","scope":"insider"},{"id":8727646,"accession":"0001209191-23-059628","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-059628","line_url":"/filing/0001209191-23-059628#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001948238","owner_name":"Pizzuti Dana","owner_url":"/insider/0001948238","role":"Officer (Chief Med and Dev Officer)","officer_title":"Chief Med and Dev Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9583.0,"shares_display":"9,583","price_per_share":34.57,"price_display":"34.57","price_state":"stated","total_value":331284.31,"total_display":"331,284.31","shares_owned_after":5911.0,"shares_owned_after_display":"5,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-21","filed_date":"2023-12-22","scope":"insider"},{"id":8628530,"accession":"0001209191-23-023469","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-023469","line_url":"/filing/0001209191-23-023469#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001948238","owner_name":"Pizzuti Dana","owner_url":"/insider/0001948238","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8212.0,"shares_display":"8,212","price_per_share":16.15,"price_display":"16.15","price_state":"stated","total_value":132623.8,"total_display":"132,623.80","shares_owned_after":4500.0,"shares_owned_after_display":"4,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-05","filed_date":"2023-04-05","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001658247","name":"Crinetics Pharmaceuticals, Inc.","url":"/issuer/0001658247","role":"Officer (Chief Med and Dev Officer)","n_filings":17,"first_seen":"2023-04-05","last_seen":"2025-12-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001948238","retrieved_at":"2026-08-21T02:05:29+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}